Abstract
The urinary excretion pattern of free and conjugated naltrexone and the metabolite 6-β-hydroxynaltrexone was determined for six human subjects for a period of 6 days after oral administration of 50 mg of naltrexone. The levels of free and conjugated drug and metabolite were determined by a gas-chromatographic analysis procedure using naloxone as an internal standard and by correlating peak height ratios to concentration. The mean excretions ± SE of free naltrexone and 6-β-hydroxynaltrexone were estimated as 1.2 ± 0.2 and 26.3 ± 2.2% of administered dose, respectively. The mean excretions of conjugated naltrexone and metabolite were estimated as 9.7 and 16.4% of administered dose, respectively. The timed urinary excretion profile indicated that naltrexone is metabolized and excreted rapidly (mean excretion t½ = 1.1 hr), whereas the free metabolite, 6-β-hydroxynaltrexone, persists at detectable levels for 6 days (mean excretion t½= 14-18 hr). Preliminary dose-ranging studies of 6-β-hydroxynaltrexone in the chronic spinal dog suggest antagonistic activity of the metabolite.
Footnotes
- Received July 15, 1974.
- Copyright © 1974 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|